Dian Diagnostics appoints Fang Mou as new securities representative

Dian Diagnostics Technology Group Co., Ltd. (Dian Diagnostics) held the fifteenth meeting of its fifth board of directors via communication voting on October 13, 2025, at 10:00 AM. Chairman Chen Haibin convened and chaired the meeting, with 8 directors participating in the vote. All 8 votes were in favor, fulfilling the requirements of relevant company and securities laws.

The board approved the resolution regarding the appointment of the company's securities affairs representative. Due to internal adjustments, Mr. Zhu Disheng will no longer serve in this role. The board has appointed Ms. Fang Mou as the new securities affairs representative. Her term will commence from the date of approval at this board meeting and conclude at the end of the fifth session of the board of directors.

Further details are available in the announcement disclosed on the Juchao Information Network on the same day.